Supernus Pharmaceuticals
SUPN
SUPN
233 hedge funds and large institutions have $1.59B invested in Supernus Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 90 increasing their positions, 67 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.52% more ownership
Funds ownership: 102.31% → 103.83% (+1.5%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
28% less call options, than puts
Call options by funds: $2.84M | Put options by funds: $3.95M
Holders
233
Holding in Top 10
2
Calls
$2.84M
Puts
$3.95M
Top Buyers
| 1 | +$9.85M | |
| 2 | +$8.88M | |
| 3 | +$6.88M | |
| 4 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$6.15M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$3.85M |
Top Sellers
| 1 | -$11.9M | |
| 2 | -$9.5M | |
| 3 | -$8.93M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$8.38M |
| 5 |
Renaissance Technologies
New York
|
-$4.36M |